← back to search

Maria Popoli

Howard Hughes Medical Institute · US
Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Pancreatic and Hepatic Oncology Research, and Cancer Immunotherapy and Biomarkers.
h-index
18
citations
6,780
works
177
NIH funding
primary concept
Medicine
email

Recent publications

Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancer
Proceedings of the National Academy of Sciences 2026cited by 5position: middledoi
Evidence that extra copies of chromosome 1q play a role in the early phases of pancreatic neoplasia
Science Advances 2026cited by 1position: middledoi
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
Nature Medicine 2025cited by 78position: middledoi
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
Nature Medicine 2025cited by 27position: middledoi
Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA
Cancer Discovery 2025cited by 12position: middledoi
Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM
Cancer Discovery 2025cited by 3position: middledoi
A Blood-Based Assay for Detection of Patients with Advanced Adenomas
Cancer Research Communications 2025cited by 2position: middledoi
NXPE1 alters the sialoglycome by acetylating sialic acids in the human colon
Nature Communications 2025cited by 2position: middledoi
TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancers
Nature Cancer 2025cited by 1position: middledoi
Circulating tumor DNA analysis informing adjuvant chemotherapy in locally advanced rectal cancer: The randomized AGITG DYNAMIC-Rectal study.
Journal of Clinical Oncology 2024cited by 36position: middledoi
Machine learning to detect the SINEs of cancer
Science Translational Medicine 2024cited by 21position: middledoi
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape
eLife 2024cited by 8position: middledoi
The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
Cancer Discovery 2023cited by 173position: middledoi
Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid
Cell Reports Medicine 2023cited by 18position: middledoi
The rapid and highly parallel identification of antibodies with defined biological activities by SLISY
Nature Communications 2023cited by 7position: middledoi
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
New England Journal of Medicine 2022cited by 948position: middledoi
An isogenic cell line panel for sequence-based screening of targeted anticancer drugs
iScience 2022cited by 14position: middledoi
Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands
Nature Biotechnology 2021cited by 90position: middledoi
Prognostic significance of postsurgery circulating tumor <scp>DNA</scp> in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies
International Journal of Cancer 2020cited by 109position: middledoi
Assessing aneuploidy with repetitive element sequencing
Proceedings of the National Academy of Sciences 2020cited by 80position: middledoi
Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer
JAMA Oncology 2019cited by 238position: middledoi
A multimodality test to guide the management of patients with a pancreatic cyst
Science Translational Medicine 2019cited by 205position: middledoi
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Science 2018cited by 2,771position: middledoi
Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers
Science Translational Medicine 2018cited by 241position: middledoi
Cancer-Associated Mutations in Endometriosis without Cancer
New England Journal of Medicine 2017cited by 612position: middledoi
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Proceedings of the National Academy of Sciences 2017cited by 569position: middledoi
Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease−Associated Colorectal Cancers
Gastroenterology 2016cited by 265position: middledoi
The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA
Clinical Cancer Research 2016cited by 177position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kenneth W. Kinzler · University of Baltimore12 papers (2016–2025)Bert Vogelstein · Clinical Pharmacology of Miami12 papers (2016–2025)Nickolas Papadopoulos · Ludwig Cancer Research12 papers (2016–2025)Lisa Dobbyn · Department of Health8 papers (2019–2026)Natalie Silliman · Howard Hughes Medical Institute8 papers (2019–2026)Janine Ptak · Howard Hughes Medical Institute8 papers (2019–2026)Chetan Bettegowda · Seattle University7 papers (2020–2025)Joshua D. Cohen · Shaare Zedek Medical Center7 papers (2019–2025)Peter Gibbs · Dubbo Hospital6 papers (2019–2025)Jeanne Tie · Peter MacCallum Cancer Centre6 papers (2019–2025)Christopher Douville · Directorate-General for Interpretation6 papers (2020–2025)Yuxuan Wang · Beijing Anzhen Hospital5 papers (2019–2025)Cristian Tomasetti · Translational Genomics Research Institute5 papers (2019–2025)Shibin Zhou · Bloomberg (United States)4 papers (2022–2025)Joy Schaefer · Minneapolis VA Health Care System4 papers (2019–2023)Surojit Sur · Bloomberg (United States)4 papers (2022–2025) · 3 papers (2022–2025)Nicolas Wyhs · Johns Hopkins University3 papers (2022–2025) · 3 papers (2022–2025)Ralph H. Hruban · Occupational Cancer Research Centre3 papers (2016–2023)